OpenURL Connection Search

Select item for more details and to access through your institution.

Arsenic trioxide represses constitutive activation of NF-?B and COX-2 expression in human acute myeloid leukemia, HL-60.
Published in:
Journal of Cellular Biochemistry, 2005, v. 94, n. 4, p. 695, doi. 10.1002/jcb.20337
By:
- Seong-Su Han;
- Kihyun Kim;
- Eun-Ryeong Hahm;
- Chan H. Park;
- Bruce F. Kimler;
- Sook J. Lee;
- Se-Hoon Lee;
- Won S. Kim;
- Chul Won Jung;
- Keunchil Park;
- Jingook Kim;
- Sung-Soo Yoon;
- Je-Ho Lee;
- Seyeon Park
Publication type:
Article
L‐ascorbic acid represses constitutive activation of NF‐κB and COX‐2 expression in human acute myeloid leukemia, HL‐60.
Published in:
Journal of Cellular Biochemistry, 2004, v. 93, n. 2, p. 257, doi. 10.1002/jcb.20116
By:
- Seong‐Su Han;
- Kihyun Kim;
- Eun‐Ryeong Hahm;
- Sook J. Lee;
- Young‐Joon Surh;
- Hye K. Park;
- Won S. Kim;
- Chul W. Jung;
- Mark H. Lee;
- Keunchil Park;
- Jung‐Hyun Yang;
- Sung‐Soo Yoon;
- Neil H. Riordan;
- Hugh D. Riordan;
- Bruce F. Kimler;
- Chan H. Park;
- Je‐Ho Lee;
- Seyeon Park
Publication type:
Article
Depletion ofl-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromes.
Published in:
European Journal of Haematology, 2009, v. 83, n. 2, p. 108, doi. 10.1111/j.1600-0609.2009.01252.x
By:
- Park, Chan H.;
- Kimler, Bruce F.;
- Seong Yoon Yi;
- Se Hoon Park;
- Kihyun Kim;
- Chul Won Jung;
- Sun Hee Kim;
- Eun Ryung Lee;
- Rha, Miyong;
- Seonwoo Kim;
- Park, Mary H.;
- Lee, Sook J.;
- Park, Hye K.;
- Lee, Mark H.;
- Sung Soo Yoon;
- Yoo Hong Min;
- Bong Seog Kim;
- Kim, Jeong-A.;
- Kim, Won Seog
Publication type:
Article

Found: 3

Arsenic trioxide represses constitutive activation of NF-?B and COX-2 expression in human acute myeloid leukemia, HL-60.

L‐ascorbic acid represses constitutive activation of NF‐κB and COX‐2 expression in human acute myeloid leukemia, HL‐60.

Depletion ofl-ascorbic acid alternating with its supplementation in the treatment of patients with acute myeloid leukemia or myelodysplastic syndromes.